Executive management
CEO since January 2024
Born 1967
MSc in Economics and Business Administration from the Stockholm School of Economics.
Boston University, School of Dental Medicine, Dean’s advisory board.
Harvard University, Harvard School of Dental Medicine, Dean’s advisory board.
University of Pennsylvania, Penn School of Dental Medicine, Board of Overseers.
President, Nobel Biocare
President, KaVoKerr
President, Ormco Corporation
President and CEO, Carestream Dental LLC
30,000 ordinary shares.
Subscribed for a total of 81,905 warrants and 4,095 employee stock options under LTI 2023.
Subscribed for 550,000 call options in Vimian at market price from Fidelio Vet Holding AB in December 2023.
Allotted 341,000 employee stock options under LTI 2024.
CFO since 2022
Born 1978
MSc in electrical engineering from the Royal Institute of Technology and MSc in economics from Stockholm University.
Owner of Calan Consulting AB.
CEO at Careium AB, CEO and CFO at DORO AB, CFO at Lekolar, Vice President Business Development at Beijer Electronics, and consultant at Capgemini Invent.
5,142 ordinary shares, 0 C shares.
Subscribed for a total of 41,071 warrants in the Company under LTI 2022.
Allotted 150,000 employee stock options under LTI 2024.
CEO of Nextmune since 2017
Born 1973
MSc in Business and Economics from the Stockholm School of Economics.
Chairman and member of the board in a number of subsidiaries within the Group including Nextmune Holding BV, Nextmune BV, Nextmune US LLC, Nextmune AS, Nextmune Scandinavia AB, Nextmune Spain S.L., Nextmune Italy S.r.l., Vetruus Limited and Bova UK Limited.
VP Corporate Strategy and M&A at Meda.
3,581,047 ordinary shares.
Allotted 150,000 employee stock options under LTI 2024.
CEO of Movora since 2020
Born 1980
MSc in Management, Technology and Economics from ETH Zürich.
Chairman of the board of KYON AG and Ossium AG. Board member of KYON Pharma (US).
CEO of Kyon, General Manager of Joint Replacement Division at Stryker and Sales Manager at Johnson & Johnson.
979,804 ordinary shares.
Subscribed for a total of 8,214 warrants under LTI 2022.
Allotted 140,000 employee stock options under LTI 2024.
CEO of VetFamily since 2022
Born 1983
MSc in Economics and Business Administration from the Stockholm School of Economics.
Chairman of the board and board member of a number of subsidiaries within the Group. Board member of Famano AB, Precis Holding AB (Precis Digital), Seenthis AB, Proxer Midco AB and Stiftelsen Vin & Sprithistoriska museet.
Group CEO of Omnicom Media Group Sweden, COO MTGx and Head of Digital MTG
Chairman of the Board OMD Sweden, Chairman of the Board PHD Sweden, Chairman of the Board Hearts & Science Sweden, Chairman of the Board Drum Sweden. Member of Board Splay Networks & Member of Board Godsmak.se.
299,638 ordinary shares and 125,170 C shares.
Subscribed for a total of 275,000 warrants in the Company under LTI 2022.
Subscribed for a total of 10,000 warrants in the Company under LTI 2023.
Allotted 120,000 employee stock options under LTI 2024.
CEO of Indical Bioscience since 2021
Born 1981
Bachelor of Economics (Honours) at LUISS Guido Carli University in Rome.
Ontario Teachers’ Pension Plan (OTPP), Bain & Company, Ernst & Young, TIM Telecom Italia, P&G.
4,500 ordinary shares, 0 C shares.
Subscribed for a total of 82,142 warrants in the Company under LTI 2022.
Subscribed for a total of 81,905 warrants and 4,095 employee stock options under LTI 2023.
Allotted 100,000 employee stock options under LTI 2024.
Head of M&A since 2021
Born 1981
MSc in Finance from the Stockholm School of Economics.
Board member of HRR Holding AB and Danzinger Gatt Invest AB.
Head of M&A at Doktor.se, Group M&A Manager at AniCura and Investment Manager at Nordic Capital.
282,802 ordinary shares.
0 warrants.
Allotted 60,000 employee stock options under LTI 2024.
Head of IR, Communications & Sustainability since 2021
Born 1981
MSc in Accounting and Financial Management from the Stockholm School of Economics.
Group Communications Director at AniCura, Head of Marketing & Communications at Moderna Försäkringar and Consultant at JKL Group.
8,342 ordinary shares, 0 C shares.
Subscribed for a total of 112,689 warrants under LTI 2022.
Subscribed for a total of 80,000 warrants under LTI 2023.
Allotted 143,612 employee stock options under LTI 2024.
General Counsel since 2022
Born 1974
Master of laws - LLM from Lund University
Bachelor of Business Administration – Finance from Lund University
Board member of Elding Oscarson Arkitekter AB
Board member of Tapster AB
Vice President and Chief Counsel International Operations at Zoetis
Assistant General Counsel at Pfizer
Attorney (Advokat) at Mannheimer Swartling Law Firm
19,660 ordinary shares.
Subscribed for a total of 112,689 warrants in the Company under LTI 2022.
Subscribed for a total of 50,000 warrants in the Company under LTI 2023.
Allotted 60,000 employee stock options under LTI 2024.